Search

Results

19 results:
Search results 11 until 19 of 19
11. Leadership … MATTHIAS E. WOHLGEMUTH Member of the Board of Directors Executive Board ANITA MATTLE Director Marketing & Consumer Health RETO SCHABERL Director Business Development & Specialty Pharma ALAIN…
12. Our Strategy … Pharmaceuticals represent Ewopharma’s most important and fastest-growing segment. Here we focus on the marketing of innovative, specialist medicines that provide significant clinical benefit and value, primarily…
13. Privacy Policy … address is Prokopa Veľkého 52, 811 04 Bratislava, Slovakia. Ewopharma International, s.r.o. acts as a marketing authorization holder within and outside EU. Our contact details are info@ewopharma.com. Phone:…
14. Cookie Policy … us for purposes such as collecting information on user behaviour, demographics, or for personalising marketing or advertising messages to you based on your browsing on the internet. Details about the third…
15. Calmino and Ewopharma join up to treat Irritable Bowel Syndrome (IBS) … in order to launch PROIBS® for the treatment of symptoms related to IBS. This agreement includes all marketing and sales activities of PROIBS® as of April 2022. Simone Thomas, Senior Product Manager at…
16. Acar’Up and Ewopharma join the fight against dust mite allergy by launching ExAller® … autumn 2020 and exclusively available in pharmacies without prescription. Mrs Anita Mattle, Director Marketing and Consumer Health, Ewopharma Group, says : «It is exciting to begin a promising partnership…
17. Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma … to new indications Can-Fite may identify for its drug candidates. Ewopharma is a pharmaceutical marketing organization that helps pharma companies access markets in CEE and Switzerland. In addition to…
18. Mead Johnson Nutrition and Ewopharma launch Nutramigen Puramino in the Czech Republic and Slovakia … Ewopharma Ewopharma AG, headquartered in Schaffhausen (Switzerland), is a pharmaceutical marketing company focused on Central Eastern Europe. With more than 50 years’ presence in the region,…
19. Licensing … existing treatment options do not adequately meet their needs. For years, we have been successfully marketing our own brand Isorpinosine®, a drug that combines both antiviral and immunomodulatory properties.…
Search results 11 until 19 of 19